Penumbra ROA 2014-2025 | PEN
Current and historical return on assets (ROA) values for Penumbra (PEN) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Penumbra ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-09-30 | $0.16B | $1.74B | 10.02% |
| 2025-06-30 | $0.15B | $1.68B | 9.43% |
| 2025-03-31 | $0.04B | $1.59B | 2.80% |
| 2024-12-31 | $0.02B | $1.53B | 0.98% |
| 2024-09-30 | $0.04B | $1.48B | 2.28% |
| 2024-06-30 | $0.01B | $1.54B | 0.91% |
| 2024-03-31 | $0.09B | $1.58B | 6.16% |
| 2023-12-31 | $0.09B | $1.56B | 6.22% |
| 2023-09-30 | $0.04B | $1.47B | 2.89% |
| 2023-06-30 | $0.03B | $1.43B | 2.17% |
| 2023-03-31 | $0.01B | $1.40B | 0.52% |
| 2022-12-31 | $0.00B | $1.37B | -0.15% |
| 2022-09-30 | $-0.03B | $1.32B | -2.39% |
| 2022-06-30 | $-0.02B | $1.33B | -1.65% |
| 2022-03-31 | $-0.01B | $1.30B | -0.63% |
| 2021-12-31 | $0.00B | $1.24B | 0.50% |
| 2021-09-30 | $0.03B | $0.97B | 3.83% |
| 2021-06-30 | $0.02B | $0.91B | 1.89% |
| 2021-03-31 | $0.00B | $0.84B | -0.61% |
| 2020-12-31 | $-0.02B | $0.82B | -2.08% |
| 2020-09-30 | $-0.01B | $0.81B | -1.37% |
| 2020-06-30 | $0.01B | $0.78B | 1.47% |
| 2020-03-31 | $0.04B | $0.66B | 6.17% |
| 2019-12-31 | $0.05B | $0.67B | 8.05% |
| 2019-09-30 | $0.05B | $0.61B | 8.06% |
| 2019-06-30 | $0.02B | $0.59B | 2.95% |
| 2019-03-31 | $0.01B | $0.57B | 2.30% |
| 2018-12-31 | $0.01B | $0.52B | 1.20% |
| 2018-09-30 | $0.01B | $0.50B | 1.63% |
| 2018-06-30 | $0.03B | $0.50B | 5.61% |
| 2018-03-31 | $0.01B | $0.49B | 2.60% |
| 2017-12-31 | $0.00B | $0.48B | 0.90% |
| 2017-09-30 | $-0.01B | $0.46B | -1.75% |
| 2017-06-30 | $0.01B | $0.42B | 1.39% |
| 2017-03-31 | $0.01B | $0.42B | 3.06% |
| 2016-12-31 | $0.02B | $0.31B | 5.15% |
| 2016-09-30 | $0.02B | $0.30B | 6.43% |
| 2016-06-30 | $0.01B | $0.28B | 2.22% |
| 2016-03-31 | $0.00B | $0.28B | 1.00% |
| 2015-12-31 | $0.00B | $0.26B | 0.76% |
| 2015-06-30 | $0.00B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $11.787B | $1.195B |
| Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $228.085B | 27.10 |
| Intuitive Surgical (ISRG) | United States | $201.399B | 78.80 |
| IDEXX Laboratories (IDXX) | United States | $57.017B | 56.62 |
| Edwards Lifesciences (EW) | United States | $48.652B | 32.62 |
| IQVIA Holdings (IQV) | United States | $41.139B | 22.94 |
| Alcon (ALC) | Switzerland | $38.961B | 26.33 |
| Mettler-Toledo (MTD) | United States | $30.332B | 35.49 |
| DexCom (DXCM) | United States | $27.399B | 37.77 |
| STERIS (STE) | Ireland | $25.505B | 26.33 |
| Waters (WAT) | United States | $23.464B | 31.03 |
| Coloplast (CLPBY) | Denmark | $20.125B | 34.35 |
| Hologic (HOLX) | United States | $16.689B | 17.53 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.475B | 0.00 |
| Globus Medical (GMED) | United States | $12.067B | 25.33 |
| Masimo (MASI) | United States | $6.974B | 22.35 |
| Glaukos (GKOS) | United States | $6.331B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $6.289B | 19.98 |
| TransMedics (TMDX) | United States | $4.877B | 57.78 |
| Teleflex (TFX) | United States | $4.592B | 7.32 |
| Veracyte (VCYT) | United States | $3.403B | 38.78 |
| LivaNova (LIVN) | United Kingdom | $3.349B | 18.09 |
| Integer Holdings (ITGR) | United States | $2.899B | 13.61 |
| Alphatec Holdings (ATEC) | United States | $2.444B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.366B | 22.14 |
| Nihon Kohden (NHNKY) | Japan | $2.034B | 17.76 |
| Artivion (AORT) | United States | $2.032B | 93.26 |
| UFP Technologies (UFPT) | United States | $1.947B | 25.71 |
| PROCEPT BioRobotics (PRCT) | United States | $1.709B | 0.00 |
| AxoGen (AXGN) | United States | $1.427B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.417B | 0.00 |
| IRadimed (IRMD) | United States | $1.263B | 60.15 |
| OPKO Health (OPK) | United States | $1.029B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.961B | 5.21 |
| Pulse Biosciences (PLSE) | United States | $0.959B | 0.00 |
| SiBone (SIBN) | United States | $0.776B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.760B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.669B | 38.90 |
| Pacific Biosciences Of California (PACB) | United States | $0.643B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.586B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.556B | 0.00 |
| NeuroPace (NPCE) | United States | $0.537B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.529B | 10.56 |
| OrthoPediatrics (KIDS) | United States | $0.469B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.466B | 12.86 |
| RxSight (RXST) | United States | $0.416B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.415B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.411B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.368B | 61.29 |
| Sight Sciences (SGHT) | United States | $0.361B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Spectral Diagnostics (EDTXF) | Canada | $0.310B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.199B | 0.00 |
| 908 Devices (MASS) | United States | $0.194B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.185B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.173B | 0.00 |
| Inogen (INGN) | United States | $0.169B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.164B | 0.00 |
| CVRx (CVRX) | United States | $0.160B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.153B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.151B | 0.00 |
| Solana (HSDT) | United States | $0.142B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.142B | 0.00 |
| LENSAR (LNSR) | United States | $0.140B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.135B | 0.00 |
| Neuronetics (STIM) | United States | $0.123B | 0.00 |
| Hyperfine (HYPR) | United States | $0.111B | 0.00 |
| Accuray (ARAY) | United States | $0.098B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.087B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.082B | 0.00 |
| DarioHealth (DRIO) | United States | $0.079B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.068B | 0.00 |
| InspireMD (NSPR) | United States | $0.067B | 0.00 |
| Positron (POSC) | United States | $0.057B | 0.00 |
| Spectral AI (MDAI) | United States | $0.049B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.022B | 0.00 |
| Envoy Medical (COCH) | United States | $0.020B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.018B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.008B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |